BiotechTube
Home/Nuvectis Pharma/Shay Shemesh
SS

Shay Shemesh

Executive Vice President, Chief Development and Operations Officer

Nuvectis Pharma

Therapeutic Areas

Oncology

Nuvectis Pharma Pipeline

DrugIndicationPhase
NXP900Advanced solid tumorsPhase 1b
NXP800Platinum-resistant, ARID1a-mutated ovarian cancerPhase 1b

Leadership Team at Nuvectis Pharma

RB
Ron Bentsur
Chairman, Chief Executive Officer and President
EP
Enrique Poradosu
Executive Vice President, Chief Scientific and Business Officer
View full Nuvectis Pharma profile